Laboratory Of Stock Z Score

LH Stock

USD 203.07 1.59 0.79%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Laboratory Piotroski F Score and Laboratory Valuation analysis.

As of now, Laboratory's Long Term Debt To Capitalization is increasing as compared to previous years. The Laboratory's current Total Debt To Capitalization is estimated to increase to 0.53, while Capital Lease Obligations is projected to decrease to under 665.4 M. As of now, Laboratory's Other Operating Expenses is increasing as compared to previous years. The Laboratory's current Cost Of Revenue is estimated to increase to about 9.5 B, while Gross Profit is projected to decrease to under 1.9 B.

Laboratory of Company Z Score Analysis

Laboratory's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Laboratory Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Laboratory is extremely important. It helps to project a fair market value of Laboratory Stock properly, considering its historical fundamentals such as Z Score. Since Laboratory's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Laboratory's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Laboratory's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Short Term Investments	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.93	0.95	0.92	0.96	0.98	0.94	0.9	-0.01	0.57	0.84	0.9	0.94	-0.73	0.31	0.8	-0.34	0.91	-0.44	0.54	-0.48	0.1	0.45	0.53	0.49	-0.68
Total Stockholder Equity	0.98		0.84	0.98	0.92	0.99	0.92	0.97	0.83	0.0	0.48	0.73	0.92	0.89	-0.66	0.37	0.85	-0.16	0.82	-0.57	0.44	-0.5	0.09	0.53	0.63	0.59	-0.78
Net Debt	0.93	0.84		0.78	0.88	0.78	0.97	0.75	0.92	0.0	0.61	0.91	0.8	0.91	-0.74	0.11	0.65	-0.63	0.97	-0.22	0.67	-0.48	0.19	0.13	0.27	0.17	-0.49
Retained Earnings	0.95	0.98	0.78		0.89	0.98	0.87	0.96	0.77	0.04	0.54	0.66	0.89	0.84	-0.7	0.36	0.81	-0.05	0.74	-0.57	0.3	-0.4	0.05	0.54	0.66	0.61	-0.8
Accounts Payable	0.92	0.92	0.88	0.89		0.87	0.88	0.85	0.76	0.13	0.54	0.68	0.93	0.8	-0.67	0.17	0.75	-0.23	0.82	-0.47	0.5	-0.65	0.35	0.23	0.47	0.27	-0.76
Net Receivables	0.96	0.99	0.78	0.98	0.87		0.89	0.98	0.8	-0.02	0.47	0.7	0.89	0.87	-0.64	0.46	0.84	-0.09	0.76	-0.58	0.39	-0.42	0.03	0.6	0.68	0.67	-0.77
Total Liab	0.98	0.92	0.97	0.87	0.88	0.89		0.87	0.93	-0.03	0.63	0.91	0.84	0.95	-0.77	0.24	0.71	-0.5	0.96	-0.3	0.62	-0.45	0.1	0.35	0.41	0.38	-0.56
Total Current Assets	0.94	0.97	0.75	0.96	0.85	0.98	0.87		0.75	-0.03	0.46	0.67	0.9	0.82	-0.62	0.47	0.83	-0.03	0.75	-0.58	0.41	-0.47	0.09	0.67	0.7	0.69	-0.78
Intangible Assets	0.9	0.83	0.92	0.77	0.76	0.8	0.93	0.75		-0.11	0.57	0.96	0.67	0.99	-0.71	0.21	0.63	-0.61	0.94	-0.17	0.6	-0.29	-0.12	0.22	0.21	0.38	-0.35
Short Term Debt	-0.01	0.0	0.0	0.04	0.13	-0.02	-0.03	-0.03	-0.11		0.26	-0.22	0.15	-0.16	-0.17	-0.07	-0.32	0.2	-0.12	-0.01	-0.1	-0.28	0.5	-0.06	0.03	-0.24	-0.25
Common Stock	0.57	0.48	0.61	0.54	0.54	0.47	0.63	0.46	0.57	0.26		0.58	0.39	0.54	-0.97	-0.15	0.03	-0.33	0.57	0.29	0.16	-0.07	0.07	0.1	0.12	0.11	-0.2
Long Term Debt	0.84	0.73	0.91	0.66	0.68	0.7	0.91	0.67	0.96	-0.22	0.58		0.57	0.95	-0.7	0.12	0.54	-0.73	0.94	-0.02	0.7	-0.25	-0.17	0.18	0.14	0.31	-0.21
Property Plant Equipment	0.9	0.92	0.8	0.89	0.93	0.89	0.84	0.9	0.67	0.15	0.39	0.57		0.73	-0.54	0.33	0.83	-0.07	0.75	-0.68	0.45	-0.68	0.43	0.43	0.57	0.35	-0.9
Good Will	0.94	0.89	0.91	0.84	0.8	0.87	0.95	0.82	0.99	-0.16	0.54	0.95	0.73		-0.7	0.25	0.72	-0.53	0.93	-0.28	0.6	-0.3	-0.13	0.32	0.33	0.47	-0.45
Treasury Stock	-0.73	-0.66	-0.74	-0.7	-0.67	-0.64	-0.77	-0.62	-0.71	-0.17	-0.97	-0.7	-0.54	-0.7		0.03	-0.24	0.36	-0.69	-0.12	-0.23	0.12	-0.01	-0.21	-0.25	-0.25	0.33
Short Term Investments	0.31	0.37	0.11	0.36	0.17	0.46	0.24	0.47	0.21	-0.07	-0.15	0.12	0.33	0.25	0.03		0.46	0.2	0.13	-0.53	0.02	-0.01	-0.03	0.64	0.42	0.56	-0.36
Current Deferred Revenue	0.8	0.85	0.65	0.81	0.75	0.84	0.71	0.83	0.63	-0.32	0.03	0.54	0.83	0.72	-0.24	0.46		-0.06	0.66	-0.78	0.37	-0.47	0.08	0.47	0.58	0.52	-0.75
Net Tangible Assets	-0.34	-0.16	-0.63	-0.05	-0.23	-0.09	-0.5	-0.03	-0.61	0.2	-0.33	-0.73	-0.07	-0.53	0.36	0.2	-0.06		-0.64	-0.41	-0.62	0.05	0.11	0.37	0.36	0.29	-0.33
Long Term Debt Total	0.91	0.82	0.97	0.74	0.82	0.76	0.96	0.75	0.94	-0.12	0.57	0.94	0.75	0.93	-0.69	0.13	0.66	-0.64		-0.19	0.7	-0.5	0.1	0.2	0.17	0.24	-0.42
Capital Surpluse	-0.44	-0.57	-0.22	-0.57	-0.47	-0.58	-0.3	-0.58	-0.17	-0.01	0.29	-0.02	-0.68	-0.28	-0.12	-0.53	-0.78	-0.41	-0.19		-0.03	0.38	-0.23	-0.48	-0.58	-0.41	0.84
Deferred Long Term Liab	0.54	0.44	0.67	0.3	0.5	0.39	0.62	0.41	0.6	-0.1	0.16	0.7	0.45	0.6	-0.23	0.02	0.37	-0.62	0.7	-0.03		-0.55	0.15	0.01	0.0	0.04	-0.11
Long Term Investments	-0.48	-0.5	-0.48	-0.4	-0.65	-0.42	-0.45	-0.47	-0.29	-0.28	-0.07	-0.25	-0.68	-0.3	0.12	-0.01	-0.47	0.05	-0.5	0.38	-0.55		-0.64	-0.15	-0.2	0.01	0.56
Short Long Term Debt	0.1	0.09	0.19	0.05	0.35	0.03	0.1	0.09	-0.12	0.5	0.07	-0.17	0.43	-0.13	-0.01	-0.03	0.08	0.11	0.1	-0.23	0.15	-0.64		-0.16	0.01	-0.48	-0.46
Cash And Equivalents	0.45	0.53	0.13	0.54	0.23	0.6	0.35	0.67	0.22	-0.06	0.1	0.18	0.43	0.32	-0.21	0.64	0.47	0.37	0.2	-0.48	0.01	-0.15	-0.16		0.71	0.86	-0.48
Net Invested Capital	0.53	0.63	0.27	0.66	0.47	0.68	0.41	0.7	0.21	0.03	0.12	0.14	0.57	0.33	-0.25	0.42	0.58	0.36	0.17	-0.58	0.0	-0.2	0.01	0.71		0.69	-0.68
Net Working Capital	0.49	0.59	0.17	0.61	0.27	0.67	0.38	0.69	0.38	-0.24	0.11	0.31	0.35	0.47	-0.25	0.56	0.52	0.29	0.24	-0.41	0.04	0.01	-0.48	0.86	0.69		-0.37
Capital Stock	-0.68	-0.78	-0.49	-0.8	-0.76	-0.77	-0.56	-0.78	-0.35	-0.25	-0.2	-0.21	-0.9	-0.45	0.33	-0.36	-0.75	-0.33	-0.42	0.84	-0.11	0.56	-0.46	-0.48	-0.68	-0.37

Click cells to compare fundamentals

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Laboratory

Based on the company's disclosures, Laboratory of has a Z Score of 0.0. This is 100.0% lower than that of the Health Care Providers & Services sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.

Laboratory ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Laboratory's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Laboratory's managers, analysts, and investors.

Environment Score

Governance Score

Social Score

Laboratory Institutional Holders

Institutional Holdings refers to the ownership stake in Laboratory that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Laboratory's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Laboratory's value.

		Shares
Norges Bank	2023-12-31	1.3 M
Bank Of America Corp	2023-12-31	1.3 M
Ubs Asset Mgmt Americas Inc	2023-12-31	1.2 M
Northern Trust Corp	2023-12-31	1.2 M
Veritas Investment Partners (uk) Ltd.	2023-12-31	1.1 M
Amvescap Plc.	2023-12-31	1.1 M
Fmr Inc	2023-12-31	1.1 M
Allspring Global Investments Holdings, Llc	2023-12-31	1 M
Nuveen Asset Management, Llc	2023-12-31	920.5 K
Blackrock Inc	2023-12-31	10.5 M
Vanguard Group Inc	2023-12-31	9.7 M

Laboratory Fundamentals

	Return On Equity	0.0423
	Return On Asset	0.0377
	Profit Margin	0.03 %
	Operating Margin	0.07 %
	Current Valuation	22.38 B
	Shares Outstanding	84.13 M
	Shares Owned By Insiders	0.34 %
	Shares Owned By Institutions	98.93 %
	Number Of Shares Shorted	1.92 M
	Price To Earning	12.69 X
	Price To Book	2.20 X
	Price To Sales	1.42 X
	Revenue	12.16 B
	Gross Profit	4.39 B
	EBITDA	1.7 B
	Net Income	379.2 M
	Cash And Equivalents	430 M
	Cash Per Share	4.63 X
	Total Debt	5.95 B
	Debt To Equity	0.63 %
	Current Ratio	1.73 X
	Book Value Per Share	93.86 X
	Cash Flow From Operations	1.33 B
	Short Ratio	2.49 X
	Earnings Per Share	4.33 X
	Price To Earnings To Growth	0.48 X
	Target Price	246.13
	Number Of Employees	56.95 K
	Beta	1.0
	Market Capitalization	16.95 B
	Total Asset	16.73 B
	Retained Earnings	7.89 B
	Working Capital	540.2 M
	Current Asset	585.1 M
	Current Liabilities	226.4 M
	Annual Yield	0.01 %
	Net Asset	16.73 B
	Last Dividend Paid	2.88

About Laboratory Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Laboratory of's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Laboratory using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Laboratory of based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Laboratory offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Laboratory's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Laboratory Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Laboratory Of Stock:

How To Invest In Laboratory

Details

Is Laboratory Stock a good investment?

Details

What is Laboratory's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Laboratory Piotroski F Score and Laboratory Valuation analysis.

Note that the Laboratory information on this page should be used as a complementary analysis to other Laboratory's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Complementary Tools for Laboratory Stock analysis

When running Laboratory's price analysis, check to measure Laboratory's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Laboratory is operating at the current time. Most of Laboratory's value examination focuses on studying past and present price action to predict the probability of Laboratory's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Laboratory's price. Additionally, you may evaluate how the addition of Laboratory to your portfolios can decrease your overall portfolio volatility.

	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas

Is Laboratory's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Laboratory. If investors know Laboratory will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Laboratory listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.46)

Dividend Share

2.88

Earnings Share

4.33

Revenue Per Share

139.628

Quarterly Revenue Growth

0.035

The market value of Laboratory is measured differently than its book value, which is the value of Laboratory that is recorded on the company's balance sheet. Investors also form their own opinion of Laboratory's value that differs from its market value or its book value, called intrinsic value, which is Laboratory's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Laboratory's market value can be influenced by many factors that don't directly affect Laboratory's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Laboratory's value and its price as these two are different measures arrived at by different means. Investors typically determine if Laboratory is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Laboratory's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Laboratory Of Stock Z Score

Laboratory of Company Z Score Analysis

Z Score

Sum Of

5 Factors

First Factor

1.2 * (

Working Capital

/

Total Assets )

Second Factor

1.4 * (

Retained Earnings

/

Total Assets )

Thrid Factor

3.3 * (

EBITAD

/

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

/

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

/

Total Assets )

Laboratory Z Score Driver Correlations

Laboratory ESG Sustainability

Laboratory Institutional Holders

Laboratory Fundamentals

About Laboratory Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Laboratory Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY